Changes Oct. 27, 2021
The following is a list of changes on monitored regulatory lists which occurred between Oct. 19, 2021 and Oct. 27, 2021.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Biocidal active substances
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole)
- 1R-trans phenothrin
- 3-iodo-2-propynylbutylcarbamate (IPBC)
- Active chlorine released from hypochlorous acid
- Active chlorine released from hypochlorous acid
- Active chlorine released from hypochlorous acid
- Active chlorine released from hypochlorous acid
- Brodifacoum
- Formic acid
- Formic acid
- Formic acid
- Formic acid
- Formic acid
- Hydrochloric acid
- Lactic acid
- Metofluthrin
- Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)
- Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)
- Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)
- Reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 1:1)
Registered substances
- (4S)-3-carbamoyl-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-1-ium (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate
- 1,1’-methylenebis(4-isocyanatobenzene) and its oligomeric reaction products with butane-1,3-diol, 2,2’-oxydiethanol and propane-1,2-diol
- 1,2,3-propanetriol glycidyl ether; 1,2,3-propanetriol, polymer with (chloromethyl)oxirane
- 1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 5-fluoro-1-[(2-fluorophenyl)methyl]-
- 2,3,3,3-TETRAFLUORO-2-[1,1,2,2,3,3,4,4-OCTAFLUORO-4-(FLUOROSULFONYL)BUTOXYL]PROPANOYL FLUORIDE
- 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-, (6S)-, (2R,3R)-2,3-dihydroxybutanedioate, hydrate (1:1:3)
- 4,5,6-Pyrimidinetriamine, 2-[5-fluoro-1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-
- 4,6-Pyrimidinediamine, 2-[5-fluoro-1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(1E)-2-phenyldiazenyl]-
- Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 17-acetate, (2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-
- Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 17-acetate, (2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-
- C16-18 (evennumbered), C18 unsaturated alkylamine ethoxylated
- Carbonic acid, diphenyl ester, reaction products with bisphenol A
- Carbonotrithioic acid, bis(phenylmethyl) ester
- Ethylamine-boron trifluoride
- N-{[1,1'-Biphenyl]-2-yl}-N-(9,9-dimethyl-9H-fluoren-2-yl)-7'-phenyl-9,9'-spirobi[fluoren]-7-amine
- Pyridinium, 1-butyl-, .mu.-chlorohexachlorodialuminate(1-) (1:1)
- Reaction mass of 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-6-methyl- and 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-5-methyl- and N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotriazole-1-methylamine and 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-4-methyl- and N,N-bis(2-ethylhexyl)-5-methyl-1H-benzotriazole-1-methylamine
- Reaction mass of Glyoxylic acid monohydrated and Glyoxylic acid dimer EC number 945-151-1
- Tetra(sodium/potassium)-7-[(E)-{2-acetamido-4-[(E)-(4-{[4-chlor-6-({2-[(4-fluor-6-{[4-(vinylsulfonyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]propyl}amino)-1,3,5-triazin-2-yl]amino}-5-sulfonato-1-naphthyl)diazenyl]-5-methoxyphenyl}diazenyl]-1,3,6-naphthalintrisulfonate
- [1,2,4]Triazino[2,1-a]cinnolin-4(1H)-one, 2,3,6,7-tetrahydro-2-(phenylmethyl)-, hydrochloride (1:?)
- methyl 5-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-carboxylate
- trisodium 3-[(E)-2-(4-{[4-chloro-6-({2-[(4-{[4-(ethenesulfonyl)phenyl]amino}-6-fluoro-1,3,5-triazin-2-yl)amino]propyl}amino)-1,3,5-triazin-2-yl]amino}-5-sulfonaphthalen-1-yl)diazen-1-yl]naphthalene-1,5-disulfonate
- trisodium 3-[(E)-2-(4-{[4-chloro-6-({2-[(4-{[4-(ethenesulfonyl)phenyl]amino}-6-fluoro-1,3,5-triazin-2-yl)amino]propyl}amino)-1,3,5-triazin-2-yl]amino}-5-sulfonaphthalen-1-yl)diazen-1-yl]naphthalene-1,5-disulfonate
Registry of CLH intentions until outcome
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol
- Copper
- Formaldehyde
- Peracetic acid
- Sodium perborate
- sodium perborate; sodium peroxoborate
- zinc ammoniate ethylenebis(dithiocarbamate)-poly[ethylenebis(thiuramdisulfide)]; metiram
- α-methyl-1,3-benzodioxole-5-propionaldehyde
Registry of restriction intentions
Substances restricted under REACH (Annex XVII)
- 1,3,6-Naphthalenetrisulfonic acid, 8-hydroxy-7-((4'-((2-hydroxy-1-naphthalenyl)azo)(1,1'-biphenyl)-4-yl)azo)-, trilithium salt
- 1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-((4'-((2-hydroxy-3,6-disulfo-1-naphthalenyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-, tetrasodium salt
- 1,3-Naphthalenedisulfonic acid, 4-amino-6-((4'-((8-amino-1-hydroxy-3,6-disulfo-2-naphthalenyl)azo)-3,3'-dimethyl(1,1'-biphenyl)-4-yl)azo)-5-hydroxy-, tetrasodium salt
- 1,6-Naphthalenedisulfonic acid, 4-amino-3-((4'-((1-amino-4-sulfo-2-naphthalenyl)azo)-3,3'-dimethyl(1,1'-biphenyl)-4-yl)azo)-, trisodium salt
- 1,7-Naphthalenedisulfonic acid, 4-amino-3-((4'-((1-amino-4-sulfo-2-naphthalenyl)azo)-3,3'-dimethyl(1,1'-biphenyl)-4-yl)azo)-, trisodium salt
- 1-Naphthalenesulfonic acid, 4-hydroxy-3-((4'-((1-hydroxy-5-sulfo-2-naphthalenyl)azo)-3,3'-dimethyl(1,1'-bip henyl)-4-yl)azo)-, disodium salt
- 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[N-(4-chlorophenyl)-3-oxobutyramide]
- 2,7-Naphthalenedisulfonic acid, 3,3'-((3,3'-dichloro-4,4'-biphenylylene)bis(azo))bis(5-amino-4-hydroxy-, tetrasodium salt
- 2,7-Naphthalenedisulfonic acid, 3-((3,3'-dimethyl-4'-((4-((phenylsulfonyl)oxy)phenyl)azo)(1,1'-biphenyl)-4-yl)azo)-4-hydroxy-, disodium salt
- 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-((4'-((2-hydroxy-4-((2-methylphenyl)amino)phenyl)azo)(1,1'-biphenyl)-4-yl)azo)-6-(phenylazo)-
- 2,7-Naphthalenedisulfonic acid, 5-[(2-amino-4-hydroxyphenyl)azo]-3-[[4'-[[7-[(2-amino-4-hydroxyphenyl)azo]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-4-hydroxy-, sodium salt
- 2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4'-[(8-amino-1-hydroxy-5-sulfo-2-naphthalenyl)azo]-3, 3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-4-hydroxy-, trisodium salt
- 2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[2-[4-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-4-hydroxy-, compd. with 2,2',2''-nitrilotris[ethanol] (1:5)
- 2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-((4'-((1-hydroxy-4-sulfo-2-naphthalenyl)azo)(1,1'-biphenyl)-4-yl)azo)-, trisodium salt
- 2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-((4'-((1-hydroxy-4-sulfo-2-naphthalenyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-, dilithium monosodium salt
- 2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-((4'-((1-hydroxy-4-sulfo-2-naphthalenyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-, monolithium disodium salt
- 2,7-Naphthalenedisulfonic acid, 6-((4-amino-2-hydroxyphenyl)azo)-3-((4'-((7-((4-amino-2-hydroxyphenyl)azo)-1-hydroxy-3-sulfo-2-naphthalenyl)azo)-3,3'-dimethyl(1,1'-biphenyl)-4-yl)azo)-4-hydroxy-, trisodium salt
- 3-[[4'-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid, sodium salt
- 4-amino-3-[[4'-[(2,4-diaminophenyl)azo]-2,2'-disulpho[1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonic acid, sodium salt
- 4-amino-3-[[4'-[(4-amino-2-hydroxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-[(4-sulphophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt
- 4-amino-3-[[4'-[(8-amino-1-hydroxy-3,6-disulpho-2-naphthyl)azo]-2,2'-disulpho[1,1'-biphenyl]-4-yl]azo]-5-hydroxynaphthalene-2,7-disulphonic acid, sodium salt
- 4-amino-3-[[4'-[(8-amino-1-hydroxy-3,6-disulpho-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-[(4-sulphophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt
- 4-amino-5-hydroxy-3-[[4'-[(2-hydroxy-1-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-6-[(4-sulphophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt
- 4-amino-5-hydroxy-3-[[4'-[(4-hydroxy-m-tolyl)azo][1,1'-biphenyl]-4-yl]azo]-6-(phenylazo)naphthalene-2,7-disulphonic acid, sodium salt
- 4-o-tolylazo-o-toluidine
- 5-amino-3-[[4'-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid, sodium salt
- 5-amino-3-[[4'-[(dihydroxyphenyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid, sodium salt
- 7-hydroxy-8-[[4'-[(4-hydroxyphenyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]naphthalene-1,3-disulphonic acid
- 7-hydroxy-8-[[4'-[(4-hydroxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]naphthalene-1,3-disulphonic acid
- A mixture of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); trisodium bis(6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)
- Actinolite
- Amosite
- Anthophyllite
- Asbestos fibres
- Azocolourants and Azodyes
- Benzoic acid, 2-((2-amino-5-hydroxy-6-((4'-((2-hydroxy-6-sulfo-1-naphthalenyl)azo)-3,3'-dimethoxy-(1,1'-biphenyl)-4-yl)azo)-7-sulfo-1-naphthalenyl)azo)-5-nitro-, disodium salt
- Benzoic acid, 5-((4'-((6-amino-5-(1H-benzotriazol-5-ylazo)-1-hydroxy-3-sulfo-2-naphthalenyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-2-hydroxy-4-methyl-, disodium salt
- Carcinogen category 1A (Table 3.1)/ carcinogen category 1 (Table 3.2) listed in Appendix 1
- Carcinogen category 1B (Table 3.1)/ carcinogen category 2 (Table 3.2) listed in Appendix 2
- Chrysotile
- Crocidolite
- Dilithium 5-[[4'-[[2,6-diamino-3-[(4-sulphonatophenyl)azo]phenyl]azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]salicylate
- Disodium 3,3'-[(2,2'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[azo(4,5-dihydro-3-methyl-5-oxo-1H-pyrazole-4,1-diyl)]]bis[4-chlorobenzenesulphonate]
- Disodium 3-[[2,2'-dimethyl-4'-[[4-[[(p-tolyl)sulphonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-2,7-disulphonate
- Disodium 4,4'-bis(2-hydroxynaphthalen-1-ylazo)biphenyl-2,6'-disulphonate
- Disodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4'-[(2-hydroxy-1-naphthyl)azo][1,1'-biphenyl]-2,2'-disulphonate